Industry News
Optos Unveils MonacoPro Ultra-Widefield and OCT Retinal Imaging Technology

Optos has announced the launch of MonacoPro, the next-generation ultra-widefield (UWF) SLO and spect...

read more
Optos Unveils MonacoPro Ultra-Widefield and OCT Retinal Imaging Technology
March 06, 2025
Avirmax Biopharma Prepares for IND-Enabling Study of ABI-201

Avirmax Biopharma has announced the initiation of Investigational New Drug (IND)-enabling studies fo...

read more
Avirmax Biopharma Prepares for IND-Enabling Study of ABI-201
March 06, 2025
Haag-Streit Launches METIS 900: A Next-Generation Ophthalmic Surgical Microscope

Haag-Streit has officially launched the METIS 900, a cutting-edge ophthalmic surgical microscope des...

read more
Haag-Streit Launches METIS 900: A Next-Generation Ophthalmic Surgical Microscope
March 05, 2025
Adverum Biotechnologies Initiates ARTEMIS Phase 3 Trial for Ixo-vec Gene Therapy in Wet AMD

Adverum Biotechnologies has announced the initiation of the ARTEMIS phase 3 study, designed to evalu...

read more
Adverum Biotechnologies Initiates ARTEMIS Phase 3 Trial for Ixo-vec Gene Therapy in Wet AMD
March 04, 2025
Nicox Announces New Data from NCX 470 Mont Blanc Trial, Provides Development Updates

Nicox, a global ophthalmology company, presented new data on its intraocular pressure (IOP)-lowering...

read more
Nicox Announces New Data from NCX 470 Mont Blanc Trial, Provides Development Updates
March 04, 2025
Opthea Publishes Phase 2b Trial Data for Wet AMD

Opthea has announced new findings from its phase 2b clinical trial evaluating sozinibercept for trea...

read more
Opthea Publishes Phase 2b Trial Data for Wet AMD
March 04, 2025
Altris AI Launches Advanced Optic Disc Analysis for Glaucoma Detection

Altris AI has introduced its Advanced Optic Disc (OD) Analysis module to enhance glaucoma detection ...

read more
Altris AI Launches Advanced Optic Disc Analysis for Glaucoma Detection
March 03, 2025
Outlook Therapeutics Resubmits BLA for ONS-5010 for Treatment of Wet AMD

Outlook Therapeutics has resubmitted its Biologics License Application (BLA) to the U.S. Food and Dr...

read more
Outlook Therapeutics Resubmits BLA for ONS-5010 for Treatment of Wet AMD
March 03, 2025
Professor Michael Belkin Honored with Lifetime Achievement Award at MIXiii 2025

Professor Michael Belkin, Head of NurExone Biologic’s Ophthalmology Project, will receive the Lifeti...

read more
Professor Michael Belkin Honored with Lifetime Achievement Award at MIXiii 2025
February 28, 2025
RetinalGenix Technologies Begins Testing Remote Ocular Monitoring System

RetinalGenix Technologies Inc. has successfully begun patient imaging using the first prototype of i...

read more
RetinalGenix Technologies Begins Testing Remote Ocular Monitoring System
February 28, 2025
More